Debt-to-equity in % of RIGEL PHARMACEUTICALS INC from Q3 2023 to Q3 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: RIGEL PHARMACEUTICALS INC quarterly Debt-to-equity history and change rate from Q3 2023 to Q3 2025.
RIGEL PHARMACEUTICALS INC Debt-to-equity for the quarter ending 30 Sep 2025 was 256 %.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	256	+844		30 Sep 2025
Q2 2025	670	+1.17K		30 Jun 2025
Q1 2025	-2.78K	-2.28K	-460%	31 Mar 2025
Q4 2024	-866	-346	-66.7%	31 Dec 2024
Q3 2024	-588	+13.4	+2.23%	30 Sep 2024
Q2 2024	-499			30 Jun 2024
Q1 2024	-496			31 Mar 2024
Q4 2023	-519			31 Dec 2023
Q3 2023	-601			30 Sep 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.